HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of a new class I antiarrhythmic drug bidisomide on canine ventricular arrhythmia models.

Abstract
The antiarrhythmic and direct cardiovascular effects of a new antiarrhythmic agent, bidisomide, alpha-(2-[acetyl(1-methylethyl)amino]ethyl)-alpha-(2- chlorophenyl)-1-piperidinebutanamide, were investigated. To determine the anti-arrhythmic effects, spontaneously occurring adrenaline-, digitalis- and two-stage coronary ligation-induced arrhythmias were used. Bidisomide suppressed these three arrhythmia models. The antiarrhythmic plasma concentration, IC50, of bidisomide for digitalis-induced arrhythmia was 22.1 micrograms/ml, and those calculated for intravenous bidisomide in 24 h and 48 h coronary ligation-arrhythmias were 15.1 and 11.6 micrograms/ml and that calculated for oral bidisomide in 24 h coronary ligation-arrhythmia was 5.4 micrograms/ml and that for adrenaline induced arrhythmia was 58.7 micrograms/ml. In the blood perfused sinoatrial node and papillary muscle preparations, bidisomide decreased the sinoatrial rate and contractile force and increased the intraventricular conduction time and coronary blood flow. These results indicate that bidisomide is similar to other class I antiarrhythmic agents such as pirmenol and KW-3401 in its antiarrhythmic profile and is expected to become a clinically useful antiarrhythmic drug.
AuthorsW Zhenjiu, T Awaji, A Hirasawa, S Motomura, K Hashimoto
JournalMolecular and cellular biochemistry (Mol Cell Biochem) Vol. 119 Issue 1-2 Pg. 159-69 (Feb 17 1993) ISSN: 0300-8177 [Print] Netherlands
PMID8455577 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Arrhythmia Agents
  • Digitalis Glycosides
  • Piperidines
  • bidisomide
  • Epinephrine
Topics
  • Animals
  • Anti-Arrhythmia Agents (pharmacology)
  • Arrhythmias, Cardiac (drug therapy)
  • Digitalis Glycosides (antagonists & inhibitors)
  • Dogs
  • Dose-Response Relationship, Drug
  • Drug Evaluation, Preclinical
  • Epinephrine (antagonists & inhibitors)
  • Female
  • Myocardial Contraction (drug effects)
  • Piperidines (blood, pharmacology)
  • Sinoatrial Node (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: